Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Dr Agarwals Eye Hospital Ltd. Share Price

NSE

BSE

NSE : DRAGARWQ

BSE : 526783

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

empty graph

Price Summary

Previous Close	₹5,160.50
Day's Range	₹5,132.00 - ₹5,269.00
Open	₹5,200.00
52 Week Range	₹4,600.00 - ₹6,059.70
Volume	590
Market Cap	₹0.00

Previous Close	₹5,165.00
Day's Range	₹5,165.00 - ₹5,220.80
Open	₹5,200.00
52 Week Range	₹4,412.05 - ₹6,392.00
Volume	40
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	30.59
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.14
Price/Earning (TTM)	32.75
TTM EPS (₹)	157.71
P/E Ratio	32.38
Book Value(₹)	6.75
PAT Margin (%)	14.89
Face Value (₹)	10.00
ROCE(%)	29.21

Trade Value ( ₹ in Lacs)	2.07
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.14
Price/Earning (TTM)	32.75
TTM EPS (₹)	157.71
P/E Ratio	32.38
Book Value(₹)	6.75
PAT Margin (%)	14.89
Face Value (₹)	10.00
ROCE(%)	29.21

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	1169.2	3971.5
Expenses	N/A	N/A
PBT	231.9	707.0
Operating profit	0.0	0.0
Net profit	172.6	546.5

Shareholding Pattern

Promoters (% Holding)

72.67%

Mutual funds (% Holding)

0.03%

Non-Institution (% Holding)

23.04%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.24%

About Dr Agarwals Eye Hospital Ltd.

Founded	1994
Managing Director	Amar Agarwal
NSE Symbol	DRAGARWQ

Peer Comparision

Stocks Name	Market Cap (Cr)(₹)	Market Price (₹)	52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd.	4,20,483.45	1,752.50	1,583.70 - 1,583.70
Divi's Laboratories Ltd.	2,49,248.45	9,389.00	5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd.	1,77,821.97	4,675.00	3,480.60 - 3,480.60
Lenskart Solutions Ltd.	1,13,750.62	656.45	0.00 - 0.00
Zydus Lifesciences Ltd.	1,11,241.63	1,115.20	835.50 - 835.50
Apollo Hospitals Enterprise Ltd.	1,10,239.70	7,667.00	6,696.50 - 6,696.50
Laurus Labs Ltd.	1,08,062.44	2,000.00	843.00 - 843.00
Cipla Ltd.	1,05,427.12	1,305.00	1,165.70 - 1,165.70
Mankind Pharma Ltd.	99,064.73	2,398.40	1,909.70 - 1,909.70
Dr. Reddy's Laboratories Ltd.	98,492.27	1,180.00	1,101.00 - 1,101.00

Latest News

Oct

8

2026

EQUITY Posted on Oct 8^th 2026

RPG Life Sciences informs about certificate

RPG Life Sciences has informed that it enclosed certificate dated October 03, 2026 issued by MUFG Intime India, Registrar and Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

8

2026

EQUITY Posted on Oct 8^th 2026

Viyash Scientific informs about allotment of equity shares

Viyash Scientific has informed that the Nomination and Remuneration Committee of the Company vide resolution passed by circulation on October 08, 2026, has approved the allotment of 1,35,880 equity shares of face value Rs. 2/- each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as detailed below: a. 79,000 equity shares at an exercise price of Rs. 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 56,880 equity shares at an exercise price of Rs.101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Consequent to the aforesaid allotment, the issued and paid-up equity share capital of the Company has increased from Rs. 88,32,55,340/- consisting of 44,16,27,670 Equity Shares of Rs. 2 each to Rs. 88,35,27,100, comprising of 44,17,63,550 Equity Shares of Rs. 2 each.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

8

2026

EQUITY Posted on Oct 8^th 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Accelerates into a HighGrowth Branded Healthcare Platform’ Two Strategic Pet-Care Deals, Premium Wellness Launches, Capacity Expansion & Bonus Issue Position Company for the Next Leg of Growth issued by the company.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

7

2026

EQUITY Posted on Oct 7^th 2026

Aashka Hospitals informs about confirmation certificate

Aashka Hospitals has informed that it enclosed the confirmation certificate received from Accurate Securities & Registry, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

7

2026

EQUITY Posted on Oct 7^th 2026

Dishman Carbogen Amcis informs about outcome of board meeting

Dishman Carbogen Amcis has informed that the Board of Directors of the Company has at its meeting held today, Wednesday, October 7, 2026 which was commenced at 13:30 pm and concluded at 14:10 pm, approved; issuance of senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures aggregating up to Rs 38 crores; modification/amendment in security in respect of the company's tranche ii of 1,500 senior, secured, rated, listed, transferable, redeemable, taxable non- convertible debentures of face value of Rs 1,00,000 each, aggregating to Rs 15 crore, allotted on september 28, 2026 having scrip code 978230.

The above information is a part of company’s filings submitted to BSE.

Read More

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Dr Agarwals Eye Hospital Ltd. ?

The current share price of Dr Agarwals Eye Hospital Ltd. is ₹5,160.50 as of 2026-10-08.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd. Share?

The market capitalisation of Dr Agarwals Eye Hospital Ltd. is ₹2,496.16 as of 2026-10-08.

What is a 1 year return for Dr Agarwals Eye Hospital Ltd. ?

The 1-year return of Dr Agarwals Eye Hospital Ltd. is % as of .

What is the P/E Ratio of Dr Agarwals Eye Hospital Ltd. Share?

The P/E ratio of Dr Agarwals Eye Hospital Ltd. is 32.38 as of 2026-10-09.

What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd. ?

The 52-week high and low of Dr Agarwals Eye Hospital Ltd. are ₹6,059.70 and ₹4,600.00, respectively, as of 2026-10-08.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore